The following clinical trials that have been conducted at QCGC Research that I have overseen as Principal Investigator and that have transformed the standard of care to patients:

Principal Investigator

Study Name

Clinical Trial Identifier

Year

Uterine Papillary Serous Trial

NCT00147680

2005

Skin Incision Study - Closure of Skin Incisions in Gynecological Cancer Surgery

NCT00107627

2005

Laparoscopic Approach to Cancer of the Endometrium

NCT00096408

2005

Laparoscopic Approach to Cervical Cancer (LACC)

NCT00614211

2008

Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer (OPEN)

NCT00850772

2009

Improving the Treatment for Women With Early Stage Cancer of the Uterus (feMMe)

NCT01686126

2012

Telephone Follow-up After Treatment for Endometrial Cancer (TEACUP)

NCT01610375

2012

Barriers for the Uptake of LaparoScopic Hysterectomy (LIgHT)

NCT02167672

2014

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

NCT02258165

2015

The Implementation of MinimAlly Invasive Hysterectomy Trial (IMAGINE)

NCT03617354

2017

Sentinel Node Biopsy in Endometrial Cancer (ENDO-3)

NCT04073706

2021

Pre-Australian National Vulvar Cancer trial

ACTRN12622000886785

2023

NODE trial

NCT06264167

2024

SATELLITE

NCT06278857

2024

Australian National Vulvar Cancer trial

NCT06476639

2024

TUBA WISP II

NCT04294927

2024

The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detection.

 

2024

Foxtrot: Feasibility test Of telehealth-delivered eXercise Therapy for Ostomates Treated for cancer.

 

2024

Chief Investigator

Study Name

Clinical Trial Identifier

Year

Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer (LEGS)

NCT00604994

2008

Ovarian cancer Prognosis And Lifestyle (OPAL)

The Australian National Endometrial Cancer Study Group (ANECS)

Exercise during CHemotherapy for Ovarian cancer (ECHO)

ANZCTRN12614001311640

2014

Measure of Ovarian Symptoms and Treatment

concerns (MOST)

ACTRN12622000886785

2021